A5003775231- Helicobacter pylori-related gastroenterology studies
- Inflammatory Bowel Disease
- Microscopic Colitis
- Liver Disease Diagnosis and Treatment
- Eosinophilic Esophagitis
- Gastroesophageal reflux and treatments
- Gastric Cancer Management and Outcomes
- Veterinary medicine and infectious diseases
- Gastrointestinal disorders and treatments
- Gastrointestinal motility and disorders
- Diet, Metabolism, and Disease
- Colorectal Cancer Screening and Detection
- Celiac Disease Research and Management
- Pharmacological Effects of Natural Compounds
- Diet and metabolism studies
- Autoimmune and Inflammatory Disorders
- Adolescent and Pediatric Healthcare
- Mycobacterium research and diagnosis
- COVID-19 Clinical Research Studies
- Colorectal Cancer Treatments and Studies
- Gastrointestinal Tumor Research and Treatment
- Colorectal Cancer Surgical Treatments
- Gut microbiota and health
- Liver Disease and Transplantation
- COVID-19 and Mental Health
University of Campania "Luigi Vanvitelli"
2016-2025
Università Cattolica del Sacro Cuore
2025
Marche Polytechnic University
2024
Ospedale Policlinico San Martino
2024
University of Genoa
2024
Elisa (Finland)
2024
University College Cork
2023
Cork University Hospital
2023
SGS Germany GmbH (Germany)
2023
University of Salerno
2015-2021
<h3>Background and aims</h3> Antimicrobial drug resistance is a major cause of the failure <i>Helicobacter pylori</i> eradication largely responsible for decline in rate. Quadruple therapy has been suggested as first-line regimen areas with clarithromycin rate >15%. This randomised trial aimed at evaluating efficacy levofloxacin-containing sequential <i>H pylori</i>-infected patients geographical area >15% prevalence versus clarithromycin-containing therapy. <h3>Methods</h3> 375 who...
Summary Background The most commonly used second‐line Helicobacter pylori eradication regimens are bismuth‐containing quadruple therapy and levofloxacin‐containing triple therapy, both offering suboptimal results. Combining bismuth levofloxacin may enhance the efficacy of rescue regimens. Aims To evaluate tolerability a regimen containing in patients whose previous H. treatment failed. Methods This was prospective multicenter study including whom standard ( PPI –clarithromycin–amoxicillin)...
Gut microbiota is involved in immune modulation and checkpoint inhibitors (ICIs) efficacy. Single-arm phase II CAVE-mCRC CAVE-LUNG clinical trials investigated cetuximab + avelumab combination RAS wild-type (WT) metastatic colorectal cancer (mCRC) chemo-refractory nonsmall cell lung (NSCLC) patients, respectively. A comprehensive gut genetic analysis was done basal fecal samples of 14 patients from trial with circulating tumor DNA (ctDNA) RAS/BRAF WT microsatellite stable (MSS) disease....
Sexual function is often impaired in patients with chronic illnesses. Several gastrointestinal and liver disorders have been shown to suffer from sexual dysfunction, celiac disease a highly prevalent gastroenterological disorder.The aim of this study was investigate the incidence risk factors for dysfunction both male female patients.Two hundred eighty-four (170 females, 114 males) participated cross-sectional observational an anonymous manner. Female assessed through Function Index...
The place regular physical activity (PA) should occupy in managing patients with inflammatory bowel diseases (IBD) is unclear.To assess PA levels and barriers a southern Italian IBD population.IBD non-severe disease [assessed partial Mayo score for ulcerative colitis (UC) Harvey-Bradshaw index Crohn's disease] were approached to receive an anonymous online questionnaire using the International Physical Activity Questionnaire (IPAQ) as patient-reported outcomes 2 (PRO-2) finally habits,...
Hericium erinaceus , berberine, and quercetin are effective in experimental colitis. It is unknown whether they can ameliorate inflammatory bowel diseases humans. This ex vivo study aimed to evaluate the anti-inflammatory potential of a nutraceutical compound HBQ-Complex ® ( H. quercetin), biotin, niacin disease patients. Tissue specimens were obtained either from Normal-Appearing Mucosa (NAM) or Inflamed (IM) 20 patients with disease. mRNA protein expression COX-2, IL-10, TNF-α determined...
Melanocortin 3 and 5 receptors (
INTRODUCTION: Patients with ulcerative colitis (UC) receiving immunosuppressive drugs are at substantial risk of colectomy. We aimed to assess the postoperative complications tofacitinib exposure before colectomy in comparison biologics. METHODS: A multicenter, retrospective, observational study was conducted patients UC who underwent total for medically refractory disease, exposed or a biologic surgery. Primary outcome occurrence any complication within 30 (early) and 90 (late) days after...
Recent studies suggest a potential relationship between rosacea and Helicobacter pylori (H. pylori) infection or small intestinal bacterial overgrowth (SIBO), but there is no firm evidence of an association H. SIBO. We performed prospective study to assess the prevalence and/or SIBO in patients with evaluated effect eradication on rosacea.